Balyasny Asset Management
GILD icon

Balyasny Asset Management’s Gilead Sciences GILD Stock Holding History

Balyasny Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Sell
12,200
-18,300
-60% -$2.56M ﹤0.01% 1860
2025
Q4 		$3.74M Sell
30,500
-8,500
-22% -$1.03M ﹤0.01% 1544
2025
Q3 		$4.33M Buy
39,000
+4,400
+13% +$500K 0.01% 1427
2025
Q2 		$3.84M Buy
34,600
+6,600
+24% +$702K 0.01% 1413
2025
Q1 		$3.14M Sell
28,000
-43,800
-61% -$4.52M 0.01% 1476
2024
Q4 		$6.63M Sell
71,800
-53,800
-43% -$4.84M 0.01% 1137
2024
Q3 		$10.5M Buy
125,600
+93,300
+289% +$7.12M 0.02% 919
2024
Q2 		$2.22M Sell
32,300
-178,900
-85% -$11.9M ﹤0.01% 1490
2024
Q1 		$15.5M Buy
211,200
+10,900
+5% +$838K 0.03% 746
2023
Q4 		$16.2M Buy
200,300
+36,300
+22% +$2.82M 0.03% 690
2023
Q3 		$12.3M Buy
164,000
+13,000
+9% +$1,000K 0.03% 768
2023
Q2 		$11.6M Hold
151,000
– – 0.03% 711
2023
Q1 		$12.5M Sell
151,000
-12,600
-8% -$1.04M 0.03% 692
2022
Q4 		$14M Buy
163,600
+3,400
+2% +$269K 0.04% 607
2022
Q3 		$9.88M Buy
160,200
+118,300
+282% +$7.46M 0.03% 689
2022
Q2 		$2.59M Buy
+41,900
New +$2.59M 0.01% 1267
2021
Q3 		– Sell
-12,800
Closed -$881K – 2111
2021
Q2 		$881K Buy
+12,800
New +$855K ﹤0.01% 1343
2020
Q3 		– Sell
-400,000
Closed -$30.8M – 1405
2020
Q2 		$30.8M Buy
+400,000
New +$30.7M 0.27% 91
2017
Q4 		– Sell
-750,000
Closed -$60.8M – 2139
2017
Q3 		$60.8M Buy
+750,000
New +$57.4M 0.24% 101
2016
Q3 		– Sell
-150,000
Closed -$12.5M – 1098
2016
Q2 		$12.5M Buy
+150,000
New +$13.3M 0.08% 306
2015
Q3 		– Sell
-50,000
Closed -$5.85M – 1225
2015
Q2 		$5.85M Buy
+50,000
New +$5.46M 0.04% 544
2015
Q1 		– Sell
-650,000
Closed -$61.3M – 988
2014
Q4 		$61.3M Buy
650,000
+430,000
+195% +$44.5M 0.56% 30
2014
Q3 		$23.4M Buy
+220,000
New +$21.5M 0.18% 141

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Balyasny Asset Management's GILD Position: Q1 2026 in Review

Balyasny Asset Management reduced its Gilead Sciences (GILD) stake by 19% in Q1 2026, selling an estimated $666K and leaving 19,774 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Balyasny Asset Management first reported a position in GILD in Q1 2015 and has held it in 35 quarters since. The position peaked at $101M in Q1 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Balyasny Asset Management held 19,774 shares of Gilead Sciences worth $2.76M as of Q1 2026.
  • Balyasny Asset Management sold 4,753 Gilead Sciences shares in Q1 2026, an estimated $666K.
  • Gilead Sciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1639 holding.
  • Balyasny Asset Management first reported a position in Gilead Sciences in Q1 2015 and has held it in 35 quarters since.
  • Balyasny Asset Management's Gilead Sciences position peaked at $101M in Q1 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.